Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Therapeutic Antithrombotic in Patients With VTE After Stroke and Hemorrhagic Tendency

NCT04726007 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT04726007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Therapeutic Antithrombotic in Patients With VTE After Stroke and Hemorrhagic Tendency
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 31, 2022
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vte after stroke